Table 1.
Reprogramming Factor | Action2 | Target Cells | Consequence | Reference |
---|---|---|---|---|
PIK3CA | + | BC3, LC4 | LC, BC, MaSC6, tumor | [34,35] |
MYC | + | IMEC5, LC | BC, MaSC, tumor | [38] |
ERBB2 | + | LC | BC, MaSC, tumor | [39] |
PyMT1 | + | LC | BC, MaSC, tumor | [39] |
SOX10 | + | LC | BC, MaSC, NCC7 | [50] |
SOX9 + Slug | + | BC, LC | MaSC, EMT8 | [19] |
TP53 | - | LC | BC, MaSC, tumor | [44–46] |
BRCA1 | - | LC | BC, tumor | [48] |
FOXA1 | - | LC | BC, tumor | [65] |
1 Polyoma virus middle T antigen; 2 activation (+) or inactivation (-) during cell reprogramming; 3 basal-lineage cells; 4 luminal-lineage cells; 5 TERT-immortalized mammary epithelial cells; 6 mammary stem/progenitor cells; 7 neural crest cells; 8 epithelial to mesenchymal transition.